Phase II trial of carboplatin (C) and bevacizumab (BEV) in patients (pts) with breast cancer brain metastases (BCBM).

被引：1
|
作者：
Lin, Nancy U.
Gelman, Rebecca Sue
Younger, W. Jerry
Sohl, Jessica
Freedman, Rachel A.
Sorensen, A. Gregory
Bullitt, Elizabeth
Harris, Gordon J.
Morganstern, Daniel
Schneider, Bryan P.
Krop, Ian E.
Winer, Eric P.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Siemens Healthcare North Amer, Malvern, PA USA
[4] Univ N Carolina, Chapel Hill, NC USA
[5] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
513
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant phase II trial with eribulin and carboplatin in patients with triple-negative breast cancer
    Giordano, Sara Barnato
    Rao, Shreyas
    Hamdan, Randala
    Jeruss, Jacqueline
    Bethke, Kevin
    Hansen, Nora
    Khan, Seema
    Von Roenn, Jamie
    Rosen, Steven
    Gradishar, William J.
    Siziopikou, Kalliopi
    Meservey, Caitlin
    Kaklamani, Virginia
    MOLECULAR CANCER RESEARCH, 2013, 11
  • [42] Hcrn GU15-215: A phase II trial of atezolizumab (atezo) and bevacizumab (bev) in cisplatin-ineligible patients (pts) with advanced/unresectable urothelial cancer (UC).
    Balar, Arjun Vasant
    Funt, Samuel Aaron
    Gupta, Shilpa
    Dudek, Arkadiusz Z.
    Boiles, Alejandro Recio
    Vaena, Daniel A.
    Kilari, Deepak
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] A Phase II Trial of Ganetespib: Efficacy and Safety in Patients (pts) with Metastatic Breast Cancer (MBC)
    Jhaveri, K.
    Chandarlapaty, S.
    Lake, D.
    Gilewski, T.
    Drullinsky, P.
    Sugarman, S.
    Wasserheit-Leiblich, C.
    Moynahan, M. E.
    D'Andrea, G.
    Haque, S.
    Patil, S.
    Bauman, L.
    Vukovic, V.
    El-Hariry, I.
    Hudis, C.
    Modi, S.
    CANCER RESEARCH, 2011, 71
  • [44] A Phase II Trial of Sunitinib in Patients With Renal Cell Cancer and Untreated Brain Metastases
    Chevreau, Christine
    Ravaud, Alain
    Escudier, Bernard
    Amela, Eric
    Delva, Remy
    Rolland, Frederic
    Tosi, Diego
    Oudard, Stephane
    Blanc, Ellen
    Ferlay, Celine
    Negrier, Sylvie
    CLINICAL GENITOURINARY CANCER, 2014, 12 (01) : 50 - 54
  • [45] A phase II trial of pemetrexed (P) plus carboplatin (C) in patients (pts) with advanced non-small-cell lung cancer (NSCLC).
    Koshy, S
    Herbst, RS
    Obasaju, CK
    Fossella, F
    Papadimitrakopoulou, V
    Pisters, KMW
    Blumenschein, G
    Peeples, BO
    Hong, WK
    Zinner, RG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 634S - 634S
  • [46] Ipilimumab in a Phase II trial of melanoma patients with brain metastases
    Margolin, Kim
    ONCOIMMUNOLOGY, 2012, 1 (07) : 1197 - 1199
  • [47] Translational Breast Cancer Research Consortium Trial 022: Neratinib and Trastuzumab-Emtansine for HER2+Breast Cancer Brain Metastases (BCBM)
    Freedman, Rachel
    Ren, Siyang
    Tayob, Nabihah
    Gelman, Rebecca
    Smith, Karen L.
    Davis, Raechel
    Pereslete, Alyssa
    Attaya, Victoria
    Cotter, Christine
    Chen, Wendy Y.
    Santa-Maria, Cesar Augusto
    Van Poznak, Catherine
    Moy, Beverly
    Brufsky, Adam M.
    Melisko, Michelle
    O'Sullivan, Ciara C.
    Ashai, Nadia
    Rauf, Yasmeen
    Nangia, Julie
    Trapani, Dario
    Savoie, Jennifer
    Burns, Robyn
    Wolff, Antonio C.
    Winer, Eric
    Rimawi, Mothaffar
    Krop, Ian
    Lin, Nancy U.
    CANCER RESEARCH, 2023, 83 (05)
  • [48] Intracranial breast cancer brain metastases (BCBM) models - stereotactic vs. intracarotid inoculation
    Cold, Sigrid
    Braig, Moritz
    Engel, Trine Bjoernbo
    Alfsen, Maria Zeiler
    Kristiansen, Maria Nikoline
    Kristensen, Lotte Kellemann
    Kjaer, Andreas
    Nielsen, Carsten Haagen
    CANCER RESEARCH, 2023, 83 (07)
  • [49] PHASE-II TRIAL OF CARBOPLATIN AND ETOPOSIDE IN METASTATIC BREAST-CANCER
    CROWN, J
    HAKES, T
    REICHMAN, B
    LEBWOHL, D
    GILEWSKI, T
    SURBONE, A
    CURRIE, V
    YAO, TJ
    HUDIS, C
    SEIDMAN, A
    NORTON, L
    CANCER, 1993, 71 (04) : 1254 - 1257
  • [50] A phase II trial of thalidomide, bevacizumab, and docetaxel in patients (pts) with metastatic androgen-independent prostate cancer (AIPC)
    Ning, Y. M.
    Arlen, P.
    Gulley, J.
    Latham, L.
    Jones, E.
    Chen, C.
    Parnes, H.
    Wright, J.
    Figg, W. D.
    Dahut, W. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345